We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Why Did Southwest Airlines (NYSE:LUV) Rise 2% After a Forecast Cut?

Southwest Airlines (NYSE:LUV), the Dallas-based carrier focused on US domestic routes, reported third-quarter 2026 results after the close on Wednesday, October 21, 2026. Revenue reached a record USD 8.4 billion, and earnings per share came in ahead of consensus estimates. The company's release said …

Vinay Lochav | 22 October 2026

Why Did Las Vegas Sands (NYSE:LVS) Miss as EBITDA Fell 17%?

Las Vegas Sands (NYSE:LVS), which owns integrated resorts in Macau and the Marina Bay Sands property in Singapore, reported third-quarter 2026 results after the close on Wednesday, October 21, 2026. EBITDA, or earnings before interest, taxes, depreciation and amortisation, fell 17% year on year, …

Vinay Lochav | 22 October 2026

Why Did Molina Healthcare (NYSE:MOH) Dip as GAAP EPS Fell 52%?

Molina Healthcare (NYSE:MOH), a managed care company focused on government-sponsored health plans, released third-quarter results on Wednesday, October 21, 2026. Total revenue was USD 11.08 billion, down about 3% from USD 11.48 billion, but above consensus estimates. Premium revenue fell 4% to USD 10.46 …

Vinay Lochav | 22 October 2026

Why Did QuantumScape (NASDAQ:QS) Jump 8% on a USD 84.5 Million Loss?

QuantumScape (NASDAQ:QS), which develops solid-state lithium-metal batteries for electric vehicles, reported third-quarter results after the close on Wednesday, October 21, 2026. The net loss narrowed to USD 84.5 million, or USD 0.17 per share. Billings, the amounts invoiced to customers and partners, reached USD …

Vinay Lochav | 22 October 2026

Why Did Medpace (NASDAQ:MEDP) Slide After a USD 4.84 EPS Beat?

Medpace (NASDAQ:MEDP), a contract research organisation that runs clinical trials for mainly small and mid-sized biotechnology companies, reported third-quarter results after the close on Wednesday, October 21, 2026. Earnings were USD 4.84 per share, against a consensus estimate of USD 4.44, or about 9% …

Vinay Lochav | 22 October 2026

Why Did United Rentals (NYSE:URI) Lift Guidance on USD 15.55 EPS?

United Rentals (NYSE:URI), which describes itself as the largest equipment rental company in the world, reported third-quarter 2026 results after the close on Wednesday, October 21, 2026. Adjusted earnings per share reached USD 15.55, against an estimate of USD 13.90, a beat of about …

Vinay Lochav | 22 October 2026

Why Did AT&T (NYSE:T) Fall 6% After a Beat and an EPS Outlook Raise?

AT&T (NYSE:T) reported third-quarter results before the open on Wednesday, October 21, 2026. Revenue rose 5.3% to USD 32.3 billion, and adjusted EPS rose 20.4% to USD 0.65, both ahead of consensus estimates. The company described the period as its best consolidated service revenue …

Vinay Lochav | 22 October 2026

Did Abbott (NYSE:ABT) Trim Its 2026 Outlook on USD 13 Billion Sales?

Abbott Laboratories (NYSE:ABT), a diversified healthcare group spanning medical devices, diagnostics, nutrition and branded generic drugs, reported third-quarter results on Wednesday, October 21, 2026. Sales were USD 13.01 billion, up 14.5% from USD 11.37 billion, or 7.0% on a comparable basis. Adjusted EPS rose …

Vinay Lochav | 22 October 2026

Why Did Thermo Fisher (NYSE:TMO) Rise 4% After Raising Its Outlook?

Thermo Fisher Scientific (NYSE:TMO), the largest supplier of laboratory instruments, consumables and outsourced drug development and manufacturing services, reported third-quarter results on Wednesday, October 21, 2026. Revenue rose 9% to USD 12.14 billion, about USD 200 million above consensus estimates. Organic growth was 6%. …

Vinay Lochav | 22 October 2026

Why Did Danaher (NYSE:DHR) Bounce After Earning USD 2.11 a Share?

Danaher (NYSE:DHR), a life sciences and diagnostics group whose businesses include bioprocessing supplier Cytiva and molecular testing company Cepheid, reported third-quarter results before the open on Wednesday, October 21, 2026. Adjusted EPS was USD 2.11, edging past consensus estimates. Revenue rose 8.5% to USD …

Vinay Lochav | 22 October 2026
Support

Hi! How can we help you today?

Loading…